1

Management Outlook and Strategic Review of Growth Action – 2010 Mid-term Initiative

September 2010 Taketsugu Fujiwara, President Asahi Kasei Corporation

2

– Disclaimer –The forecasts and estimates shown in this document are dependent on a variety of assumptions and economic conditions. Plans and figures depicting the future do not imply a guarantee of actual outcomes.

Contents1. Overview of Asahi Kasei 3–4

2. Growth Action – 2010 mid-term business plan 5–7

3. Business performance and revision of actions, outlook, and capex

8–11

4. Forecast for FY 2010 12–14

5. Strategy and actions by segment 15–18

6. Progress of Growth Action – 2010 19

7. Long-term socio-economic trends 20–24

8. Concept for the next management initiative 25–37

9. Concept for return to shareholders 38

3

Chemicals

Health Care

Homes

Fibers

Electronics

Others*

Construction Materials

Sales: 1,677 Operating Income: 80

16

1.5

2

29

28.5

9

1.5

416

123

50

18

167

105

798

FY10 forecast in May, ¥ billion

A diversified chemical company with housing and electronic devices

Chemicals & Fibers 54%

Homes & Const. Mat.

28%

Electronics 10%

Health Care Pharmaceuticals &

medical devices 7%

Share of sales by business sector

1. Overview of Asahi Kasei

* Others category replaces the former Services, Engineering and Others segment. Operating expenses of one consolidated subsidiary previously included in Services, Engineering and Others are now included in corporate expenses and eliminations (no impact on sales, immaterial impact on operating income).

4

2009

1950 19801965

History of business portfolio transformation, change of sales composition

1995

Bemberg™ regenerated cellulose

Rayon fiber Acrylic fiberNylon fiber Chemicals

Housing & Const. Mat.

Health CareElectronics

Expansion into synthetic fiber businesses

• Construction of petrochemical complex

• Start of housing business

• Start of LSI and dry film photoresist businesses

• Formation of pharmaceuticals business unit and consolidation with Toyo Jozo Co., Ltd.

• Development of housing business

• Business portfolio restructuring

• Expansion of global businesses

Business portfolio transformation

aligned with new currents

Fibers

Housing & Const. Mat.

Chemicals

5

Shifting to growthIshin2000FY 1999–2002

Disposal of negative legacies

Selectivity and focus

Ishin-05

Selective diversificationCreation of cash flow

Management speed and autonomy*

FY 2003–2005FY 2006–2010

Growth Action – 2010

Strategic investment

Business portfolio realignment for expansion

and growth

* Transition to holding company configuration in Oct. 03.

Expanding global

businesses

Enhancing domestic

businesses

Electronic devices

Medical devices

Electronic materials

Chemical- based,

specialized function

High growth businesses

Monomers(Acrylonitrile, MMA,

styrene monomer, etc.)

Polymers(including processed

products)

Domestic businesses

(Housing, construction materials, pharmaceuticals, home-use products, etc.)

Stable growth, stable earnings businesses

２. Growth Action – 2010 mid-term business plan

6

Investment from FY 2003 to FY 2005 70 to 80/year

Strategic investment for FY 2006 to FY 2010 400

Total for FY 2006 to FY 2010 800

(¥ billion)

Organic 220

M&A 150

Resources for dividends 30

Strategic investment for continuous profit growth and dividends increase

Strategic investment

Continuous dividends increase

(Basic standard for payout ratio: 20–30%)

Continuous earnings increase(6% p.a. for net income)

Share buybacks

Breakdown

7

FY 2005

FY 2006

FY 2007

FY 2008

FY 2009

FY 2010 forecast in May

FY 2010 original target

Net sales 1,498.6 1,623.8 1,696.8 1,553.1 1,433.6 1,677 1,800

Operating income 108.7 127.8 127.7 35.0 57.6 80 150

Net income 59.7 68.6 69.9 4.7 25.3 42.5 80

Dividends ¥10 ¥12 ¥13 ¥10 ¥10 ¥10 －

Payout ratio 23.6% 24.5% 26.0% 295.0% 55.3% 32.9% －

ROE 10.8% 11.1% 10.7% 0.7% 4.1% 6.6% ≥10%

ROA 4.5% 4.8% 4.8% 0.3% 1.8% 3.0% ≥5%

(¥ billion)

Targets in FY 2010

8

0.0

20.0

40.0

60.0

80.0

100.0

120.0

140.0

160.0

2005 2006 2007 2008 2009 2010

Minus ¥73.7billion from FY07in Chemicals and

Fibers

Minus ¥18.9 billionfrom FY07 inElectronics

Substantial decline due to the economic downturn

Course of operating income

Operating income 108.7 127.8 127.7 35.0 57.6 80.0Net income 59.7 68.6 69.9 4.7 25.3 42.5

(¥ billion)

FY *

* Forecast in May 2010.

Baseline for G

rowth Action –

2010 target

Grow

th Action –

2010 target

Grow

th Action –

2010 target

Grow

th Action –

2010 target

Grow

th Action –

2010 target

Forecast

3. Business performance and revision of actions, outlook, and capex

9

Responding to challenges

Business portfolio realignment for expansion and growth

High-growth businesses→

Electronic devices & materials, medical devices, specialty chemicals

Basic concept of Growth Action – 2010

Expansion of electronics businesses from perspective of energy and resource conservation

Expansion and globalization of pharmaceutical and medical device businesses to meet emerging needsFurther enhancement of high-value added businessesAcceleration of portfolio realignment through R&D, M&A

Actions

Streamlining of general-use/commodity businesses

Priority on profitability andinvestment efficiency

Additional actionsExpanding

global businesses

Reinforcement & growth

New business creation

Enhancing domestic

businesses

Higher added value

Development of services

10

(Decision adopted, ¥ billion)

Revision of 5-year capex plan (as of June 2009)

Original plan (a)

Revised plan (b)

Decrease from original

plan (b-a)

Maintenance 200 195 (5)

Expansion 360 240 (120)

R&D 40 40 0

M&A 150 150 0

Sub-total 550 430 (120)

Renewing petrochemical complex 20 15 (5)

Dividend, restructuring, etc. 30 30 0

Total 800 670 (130) ¥100 billion + α

(M&A)

Financial strength

• Maintaining D/E ratio of ≤0.5 to secure financing ability; capital expenditure of ¥670 billion by FY 2010 (¥130 billion decrease).

• Curtailment of working capital with sales decrease.• Review of investments for expansion with change in management climate.

Plan for FY10

¥40 billion

¥50 billion

¥10 billion

11

Revision of FY 2010 outlook (as of June 2009)

(¥ billion)

Sales Operating income

Chemicals & Fibers 600–650 16–23

Homes & Const. Mat. 450–480 20–23

Electronics 150–200 18–24

Health Care 130–150 12–16

Others 20 (6)

Total 1,350–1,500 60–80

Original forecast 1,800 150

FY 2010 outlook

12

FY 2010 Consolidated operating performance

(¥ billion)

FY Increase H1 20102008 (decrease) forecast

Net sales 1,553.1 658.6 774.9 1,433.6 792.0 885.0 1,677.0 243.4 789.0

Operating income 35.0 18.0 39.7 57.6 31.5 48.5 80.0 22.4 52.0

Ordinary income 32.5 15.1 41.3 56.4 31.0 46.5 77.5 21.1 48.0

Net income 4.7 4.2 21.0 25.3 13.0 29.5 42.5 17.2 23.0

 Naphtha price (¥/kL, domestic)

58,925 37,250 45,100 41,175 50,000 50,000 50,000 8,825 46,350

 ¥/US$ exchange rate (market average)

101 95 90 93 90 90 90 (3) 90

FY2008

FY2009

FY 2010 H1 2010

¥5(planned)

Payout ratio 295.0% 55.3%

in Aug.

32.9%

FY 2009 FY 2010 forecast in May

H1 H2 Total H1 H2 Total

(planned)Dividends per share ¥10 ¥10¥10

4. Forecast for FY 2010

13

FY 2010 Sales forecast by segment

(¥ billion)

Increase H1 2010(decrease) forecast

in Aug.

Chemicals 293.3 328.8 622.1 391.0 407.0 798.0 175.9 386.0

Homes 157.7 232.0 389.7 176.0 240.0 416.0 26.3 174.0

Health Care 56.3 56.9 113.2 59.0 64.0 123.0 9.8 58.0

Fibers 48.7 52.5 101.2 51.0 54.0 105.0 3.8 53.0

 Electronics 68.5 74.2 142.7 81.0 86.0 167.0 24.3 85.0

Construction Materials 24.6 22.4 47.0 25.0 25.0 50.0 3.0 24.0

 Others* 9.6 8.0 17.6 9.0 9.0 18.0 0.4 9.0

Consolidated 658.6 774.9 1,433.6 792.0 885.0 1,677.0 243.4 789.0

FY 2009 FY 2010 forecast in May

TotalH2H1TotalH2H1

* Others category replaces the former Services, Engineering and Others segment.

14

FY 2010 Operating income forecast by segment

(¥ billion)

FY 2009 FY 2010 forecast in May Increase H1 2010(decrease) forecast

in Aug.

Chemicals 11.5 14.6 26.1 15.5 13.0 28.5 2.4 32.0

Homes 4.1 21.2 25.3 7.0 22.0 29.0 3.7 8.5

Health Care 3.4 0.6 4.0 3.5 5.5 9.0 5.0 3.5

Fibers (2.9) 0.1 (2.8) 0.5 1.5 2.0 4.8 1.5

 Electronics 2.8 4.4 7.2 7.5 8.5 16.0 8.8 9.5

Construction Materials 0.6 0.6 1.2 1.0 1.0 2.0 0.8 1.0

 Others* 1.0 0.8 1.8 0.5 1.0 1.5 (0.3) 0.5

 Corporate Expenses and Eliminations

(2.6) (2.6) (5.3) (4.0) (4.0) (8.0) (2.7) (4.5)

Consolidated 18.0 39.7 57.6 31.5 48.5 80.0 22.4 52.0

H2 TotalH1 H2 Total H1

* Others category replaces the former Services, Engineering and Others segment. Operating expenses of one consolidated subsidiary previously included in Services, Engineering and Others are now included in corporate expenses and eliminations (no impact on sales, immaterial impact on operating income).

15

Field Expansion of established business

Overseas development

New business/ new product

Restructuring/ streamlining

Electronic devices

• LSI capacity expansion • Incorporation of local sales subsidiaries for LSIs in China, Europe, and Korea.

• Market Launch and expansion of electronic compass business.

• Entry into power management LSI business by acquisition of semiconductor business from Toko Inc.

• Reorganization

Electronic materials

• Capacity expansion for Hipore™ Li-ion battery separator: plant expansion in Moriyama and new plant in Hyuga.

• Capacity expansion for Pimel™ semiconductor buffer coats.

• New production line for photomask pellicles for 10G LCD panels.

• Dry film photoresist capacity expansion in China.

• Establishment of pellicle sales subsidiary in Taiwan.

• Strategic alliance in optical materials with Luminit, LLC.

• Reorganization

Electronics

Field Business strategy

Electronic devices

• Expansion of LSI business: enhanced design function, new fields of application, new geographical markets.

• Expansion and development of sensor/LSI hybrid device businesses.

Electronic materials

• Expansion, higher added value, new applications in established businesses.

• Creation of new businesses.

5. Strategy and actions by segment

Business strategy of Growth Action – 2010

Actions performed

16

Field Expansion of established business Overseas development New business/

new product

Devices

• Capacity expansion for artificial kidneys.

• Integration of dialyzer business with Kuraray Medical Inc.

• Capacity expansion for Planova™ virus removal filters.

• Market launch of Planova™ BioEX, virus removal filters specifically designed for biopharmaceuticals processing.

• Capacity expansion for Sepacell™ leukocyte reduction filters.

• New plant for therapeutic apheresis devices.

• New assembly plant for artificial kidneys in China, expansion of same.

• Multi-faceted business alliance with NxStage Medical, Inc., home dialysis system company.

• Alliance in dialyzer business with Kawasumi Laboratories, Inc.

• Establishment of sales subsidiaries in China, Taiwan, and Korea.

• Decision to acquire all shares of Med-Tech Inc.— now a consolidated subsidiary of Asahi Kasei Kuraray Medical.

• Acquisition of bioprocess equipment business of TechniKrom, Inc.

• Launch of advanced medical device business:

- Market launch of Reveal® DX insertable cardiac monitor

- Start of clinical study for Evaheart™ ventricular assist system in the U.S.

Pharma- ceuticals

• Acquisition of intellectual property rights related to naftopidil, an agent for treatment of benign prostatic hyperplasia.

• Overseas development of Recomodulin™ recombinant thrombomodulin.

• Reinforcement of sales promotion for Eril™ rho-kinase inhibitor in China.

• Approval and market launch of two new products, Recomodulin™ recombinant thrombomodulin and Famvir™ anti-herpes agent.

Health Care

Reveal® is a registered trademark of Medtronic, Inc. Evaheart™ is a trademark of Sun Medical Technology Research Corp.

Field Business strategy

Devices• Advancing toward a top-class global business in blood purification systems.

- Global expansion of artificial kidney business.- Accelerated development of pipeline in therapeutic fields.

Pharma- ceuticals

• Focus on orthopedics, central nervous system, and urology.• Dynamic use of alliances with other companies.

Business strategy of Growth Action – 2010

Actions performed

17

SegmentExpansion of established business

Overseas development

New business/ new product Restructuring/streamlining

Chemicals

• Capacity expansion for ion-exchange membranes.

• Capacity expansion for synthetic rubber.

• Conclusion of final agreement for AN and MMA joint venture with PTT in Thailand—plants under construction.

• New plant for Duranate™ HDI-based polyisocyanate in China.

• New assembly plant for water treatment membranes in China.

• Start of wastewater recycling business.

• Closure of 150,000 ton/year styrene line.• Consolidation of fertilizer business.• Integration of industrial explosives

operations.• Divestment of shareholding in PS joint

ventures in China.• Streamlining of operation in Mizushima:

RING project, etc.• MOU for unification of naphtha cracker

operations in Mizushima.• Decision to discontinue ammonia and

benzene production.

Fibers

• Capacity expansion for Roica™ spandex in China and Thailand.

• Launch of Asahi Kasei China Fashion Design Creativity Awards.

• Launch of Precisé™ multifunctional nonwoven.

• Establishment of new R&D and technology center.

• Closure of polyester filament plant and withdrawal from the field of monofilament.

• Decision to dissolve Solotex Corp., joint venture for polytrimethylene terephthalate (PTT) fiber with Teijin Fibers Ltd., and withdraw from PTT fiber operations.

Chemicals & Fibers

Segment Business strategy

Chemicals,Fibers

• Volume products - Global expansion of businesses based on superiority and originality.

• Specialty products - Market expansion based on technological strengths.- Enhanced R&D, creation of new businesses.

Business strategy of Growth Action – 2010

Actions performed

18

Segment Expansion of established business New business/new product Restructuring/

streamlining

Homes

• Reinforcement of promotion with Hebel Haus™ “street-corner showrooms.”

• Reformation of sales framework.• Market launch of new products:

Fine Hebel Haus™, Smart Hebel Haus™, Hebel Haus™ homes featuring electric power generation, Hebel Haus™ Frex “G3”, etc.

• Establishment of new housing R&D center.

• Development of new framing structure for energy conservation.

• Start of materials procurement alliance.

Construction Materials

• DynaWing™ pre-cast concrete piling system featuring minimal soil disposal and high load-bearing capacity.

• Freedonut™ system for reinforcement openings to pass plumbing/wiring through I-beams.

• CSV™ soil improvement system for small-scale architecture.

• Divestment of artificial fish reef business.

• Restructuring of construction materials business: closure of Shiraoi plant and one of two lines in Hozumi for autoclaved aerated concrete.

Homes & Construction Materials

Segment Business Strategy

Homes • Eliciting demand for rebuilding.• Extension of “Long Life Home” strategy.

Construction Materials

• Growth in insulation materials.• Synergies with housing operations.• Greater management emphasis on customer perspective.

Business strategy of Growth Action – 2010

Actions performed

19

Results at presentActions achieved/in progress

• Investment for expansion in high-growth businesses-Electronics: Hipore™, dry film photoresist in China, LSIs, acquisition of semiconductor business from Toko Inc.-Medical devices: Artificial kidneys, Sepacell™, Planova™, acquisition of business of TechniKrom, Inc.,

purchase of Med-Tech Inc. shares. -Chemical specialties: Ion-exchange membranes, water treatment membranes in China, Duranate™ in China.

• Expansion of commodity businesses with competitive superiority-Investment for new acrylonitrile (AN) plant in Thailand.

• Streamlining of general-use/commodity businesses and production optimization-MOU for establishment of joint venture for unified naphtha cracker operations in Mizushima to cope with increased capacity in Middle East and China.

-Restructuring and enhanced configuration in Fibers and Construction Materials.• Transition to operational framework premised on shrinking housing market

-Fewer model homes and more Hebel Haus™ “street-corner showrooms.”-Reorganization of marketing structure.-Reinforcement of organization for expansion of housing-related businesses.

Not achieved

• Initial targets• Creation of new businesses, esp. in electronic materials and chemical specialties• Large-scale M&A for significant business expansion• Improvement of profitability in Fibers and Construction Materials

6. Progress of Growth Action – 2010

20

0

200

400

600

800

1,000

1,200

1980

1983

1986

1989

1992

1995

1998

2001

2004

2008

2011

2014

2017

2020

(¥ trillion)

Maturity and decline of Japanese economy

0

20

40

60

80

100

120

140

1920

1930

1940

1950

1960

1970

1980

1990

2000

2010

2020

2030

2040

2050

0%

5%

10%

15%

20%

25%

30%

35%

40%

45%

50%

Population (left scale)

Ratio of people aged 65 and over (right scale)

People aged 65 and over (left scale)

(million people)

7．Long-term socio-economic trends

Source: National Institute of Population and Social Security Research

Forecast for public debt from Ministry of Finance. Japanese government forecast for FY 2010 GDP. GDP for FY 2011 and after calculated based on 2% & 3% growth rates.

2% growth3% growth

Nominal GDP

Forecast

Public debt

Japanese PopulationJapanese Nominal GDP and public debt

21

0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

80,000

00 02 04 06 08 10 12 14

Growth of world economy

Others

BRICs

US

Japan

Europe

Global GDP

Growth rate from 2010

to 2015

+3%

+3%

+4%

+11%

+6%

Source: International Monetary Fund

0.0

0.1

0.2

0.3

0.4

0.5

0.6

0.7

0.8

0.9

1.0

90 95 00 01 02 03 04 05 06 07 08

China

India

Others*

* Korea, Taiwan, Singapore, Thailand, Indonesia, Malaysia, Philippines, and Vietnam

Middle-income population in Asia(billion people)

Population with annual household income between $5,001 and $35,000

(US$ billion)

Source: METI Trade White Paper

22

Challenges and constraints to growthChallenges Constraints

Environmental deterioration

Waste, urban congestion, etc.

Resource shortages・Materials・Energy・Food・Water, etc.

Necessity of solution, including change in lifestyle

-

100

200

300

400

500

600

700

800

1990 2000 2006 2010 2020 2030

Source: Energy Information Association

Energy demand forecast

US

China & India

Others

(quadrillion Btu)

* Japan, European countries, etc.

Brazil

Other developing countries

India

China

US

Countries specified in Appendix I except US*

Forecast of global CO2 emissions

Source: Research Institute of Innovative Technology for the Earth

23

Other subjects

4%

5%

6%

7%

8%

9%

10%

96 97 98 99 00 01 02 03 04 05 06 07 08

0

10

20

30

40

50

60

70

80

90

100Medical expenses/national income (left side)

Drug price index, 1990=100 (right scale)

0

2

4

6

8

10

12

14

16

18

20

80 85 90 95 00 05 10 15 20 25 30

Parents with children

Single persons

Couples

Japanese national medical expenses

Number of Japanese households

0

20

40

60

80

100

120

140

160

180

00 01 02 03 04 05 06 07 08 09 10 11 12 13100%

105%

110%

115%

120%

125%

130%

135%

140%Asia excluding JapanMiddle EastOthersWestern Europe and North AmericaJapanCapacity/demand (right scale)

Ethylene production capacity(million tons)

(million households)

Source: National Institute of Population and Social Security Research

Lehman shock

24

1.Respond to upcoming trends based on present trends and social changes

2.Develop innovative, world- changing technology

3.Develop business in emerging countries

Trends of large global companies

Future of developed countries incl. Japan

Rising world population

Facing upcoming socio-economic developments

What we need to doWhat we need to do

Food supplies

Ensuring the security of energy & resources

Spread of information and communication

networks

Growth of emerging countries

Circumstances for Japan

25

Basic tenets of the Asahi Kasei Group

Contribution to human life and human livelihood through constant innovation and advances based in science and the human intellect.

People Society

Amidst drastic changes on a global scale, we need to do the following based on our basic tenets.

Help society progress in harmony with the natural environment on a global scale.

Enable each individual to live in health and comfort.

8. Concept for the next management initiative

26

Management responding to the needs of the times

Development of businesses providing solutions for the needs of the times

Needs of the times

Establishment of livelihood base

Sufficiency of daily necessities

• Improvement in quality of life

• Development of social capital

Consumeristic society, fossil fuel civilization, and high growth period

Limitation of civilization based on mass production and mass consumption

Convenience and comfort

Responding to challenges in the new era

• New challenges• Unsolved and untouched challenges

Low birthrate and longevity

Maturing

Growth •Chemical fertilizer

•Regenerated fiber

•ExplosivesIncubation

•Synthetic fibers

•Petro- chemicals

•Pharmaceuticals•Medical devices•Electronics

•Construction materials

•Housing

1920s 1950s 1970s1960s

1. Harmony with the natural environment

2. Living in health and comfort

27

Responding to the needs of the new era

Strategic concept and values in the Asahi Kasei group

Harmony with the natural environment

Living in health & comfort

Core Operating Companies & New

Business Development

Fibers, Chemicals

Housing, Construction Materials

Electronics Health Care

New businesses

Contribution to human life and human livelihood in the future

28

Growth Action – 2010 (2006–2010)Expansion of global businesses, such as electronics, medical devices, chemical specialties, AN, etc., and creation of new businesses with global potentialEnhancement of domestic businesses

Ishin-05 (2003–2005)Management speed by transition to holding company configurationFocus on high-value added businesses

Ishin-2000 (1999–2002)Selectivity and focusAutonomy by self-responsibilityEconomical management

Management to succeed in international competition

Selective diversification

Business portfolio realignment for expansion and growth

Conventional conceptEnhancement of each business & pursuit of each possibility

Management aiming toward the same direction in every business with the following perspectives

Harmony with the natural environmentLiving in health and comfort

Concept for the new mid-term management initiative (1)

No change

Fresh approach to creating new businesses

New Concept

Established businesses:•Review based on the above perspectives

•Pursuit of shift to stable profit structure

29

Aiming to create new markets rather than clinging to shrinking markets

Applying these two perspectives in the evaluation of businesses

Economic evaluation• P/L• B/S & C/F• ROIC, EVA, etc.

Evaluation of business execution and change of business portfolio based on these perspectives

= Equal

weighting

Concept for the new mid-term management initiative (2)

1. Harmony with the natural environment2. Living in health and comfort

30

Guideline concept for all businesses

Accelerating expansion of global businesses

Reexamining each business based on the two perspectives of harmony with the natural environment and living in health & comfort, finding new directions in which to expand

Pursuing ultimate business structure with stable profitability

• Discerning the core value of each business: considering “fabless” model, e.g. pile business of construction materials

31

1. Accelerating expansion of global businessesAcrylonitrile (AN) • Securing optimum production locations around the worldSynthetic rubber • Securing C4 sources and developing Asian markets

2. Business expansion based on harmony with the natural environment and living in health & comfort

Natural environmentEnergy efficiency, IT, break from fossil fuels, reduced environmental burdens

Electronic devices • Developing new applications in power management, etc.• Expanding sensor device business• Reinforcing global marketing and R&D

Li-ion battery separator • Maintaining leading global position in established applications• Expanding in automotive applications• Commercializing related devices & materials

Dry film photoresist • Expanding business AsiaWater treatment • Expanding both membranes and related water-treatment businesses

Health & comfort

Medical/biotech devices • Expanding worldwide in artificial kidneys, therapeutic apheresis devices, and Planova™ virus removal filters- Developing system-based solutions

• Early launch of advanced medical devices- Insertable cardiac monitor, ventricular assist system, etc.

Pharmaceuticals • Expanding domestic sales & accelerating overseas development for Recomodulin™ recombinant thrombomodulin

• Targeting 2012 launch synthetic PTH as a new core product• Reinforcing drug development pipeline

- Focusing on unmet medical needsHomes • Creating new opportunities in urban homes

- Providing innovative lifestyle proposals with new products for comfortable living & environmental friendliness

• Expansion of post-construction businesses such as remodeling3. Pursuing stable profitability & enhanced operating base

• Maintaining/enhancing high market position & creating steady cash flow- Ion-exchange membranes, Bemberg™ regenerated cellulose, Saran Wrap™ cling film, etc.

Approach to advancing each businesses

32

Fresh approach to creation of new businesses

Provision of systems and services which connect with the Japanese government’s vision for a new society*.Creation of technology for harmony with the natural environment and living in health & comfort.

• Pursuing systems in fields where we can utilize our strength by combining diverse devices, components, and products.

• Active utilization of collaboration with other companies and M&A.Recognition of challenges for achievement

Establishment of human resources development, culture, and evaluation standards suitable for system- and service-based businesses.

* Examples include:• Society in which people utilize renewable energy.• Society in which people recycle water and rare metals.• Society in which it is possible to implement medical diagnoses at home and remote monitoring

by using information systems.

Contribution and participation in

new societyProvision of systems & services

Harmony with the natural environmentLiving in health & comfort

Devices

ComponentsProducts

Combining diverse devices, components, and products

Collaboration with other companies

M&A

33

Opportunity to create new businesses (1) Environment & Energy

Storage battery・Battery-related materials・Next-generation battery & materials

Fuel cell materials

Wind power plantNuclear power plantThermal power plant

Separation of CO2

Solar power plant:• Peripheral material such as

encapsulants, surface coating material.• Next-generation solar cells

(higher efficiency, sheet type)

Energy-saving lighting・Encapsulants・Diffusion film・High-power LED materials Effective utilization of energy

(housing materials, design, fixtures, and controls)

Solar cells・

Peripheral material such as encapsulants, surface coating material.

“Eco-town”Town design for energy management

Electric vehicle

Solar panels

Storage battery

Storage battery

High-R insulationLightweight materialCoating material w/photocatalyst

Hubs of energy saving and energy buffering

Insulation V2G = Vehicle to GridV2H = Vehicle to Home

Electric vehicle

Smart meter

Combination of housing, electronic devices, and electronic materials (Underlined fields have potential for new businesses)

Solar power plant

Energy-saving equipment(Sensors which detect people)

34

Growing world population, economic development of emerging countries, uneven distribution of resources, environmental degradation

Water purificationSeparation membranesMercury-free disinfection (LED etc.)

Plant effluent treatment system(UF, MF, RO)

Seawater desalination・Innovative separation membranes

Small-scale water disinfection

Phosphorus recovery Wastewater treatment

Prevention of eutrophication

Separation of CO2 /H2

Thermal power plant

Vehicle motors

Water Elements

Electronic devices

Separation & recoveryRare earth, rare metal, widely-used elements,phosphorus, potassium, lithium, etc.

Gas

Membrane separation of water / organic substances

Nitrogen enrichment

Air purification

Opportunity to create new businesses (2) Effective utilization of water & rare metalsCombination of membranes, chemicals, and electronic devices (Underlined fields have potential for new businesses)

35

Remote diagnosis & displayInsertable cardiac monitor

Opportunity to create new businesses (3) Health, ICT, and broadband

Remote guidance for nutrition and exercise

Agricultural productsAnalysis of nutritional value Elderly single-

person household

Home & remote diagnosis

Health consultation

Diagnosis at home

Medical consultation for the elderly

Remote monitoringRemote diagnosis

Advanced medical careAdvanced medical devices such as artificial kidneys and artificial heart.Biopharmaceuticals production process.Leukocyte reduction.Medical device-related components, etc.

Young households

(ICT=Information and Communication Technologies)

Combination of medical devices, housing, and electronic devices (Underlined fields have potential for new businesses)

Care facilities, monitoring

36

Maturing businesses

New businesses, growth businesses

Global

Review of established businesses based on the two perspectives: Pursue shift toward the upper right in the above chart. Positively evaluate businesses which earn profit (EVA) & gain resources for investment in high-growth businesses, even if they don’t match the perspectives (remain in the lower left).Withdraw from non-profitable businesses.

Perspectives• Harmony with the natural

environment• Living in health & comfort

Japan

Present

Overall shift of management resources

37

Summary1. Review of Growth Action – 2010

Some tasks uncompletedEstablishment of operating constitution capable of generating record-level operating income・Full contribution from investments forthcoming

2. Direction of the next initiativeStrategic perspectives: Harmony with the natural environment and living in health & comfort・Adapting to changes in socio-economic climate

Management to efficiently utilize the overall strength of the group3. Growth & expansion strategy

In businesses or fields where we have unique strengths:・Transform to system-based business model・Heighten presence in growth markets around the world

Capital investment considerably exceeding depreciation・Execute large-scale investments and M&A, not strictly bound by D/E ratio

target if conditions are sufficiently favorable4. Challenges & responses for implementation

Transform culture and mind with top management taking the leadCreate new evaluation standards suitable for system-based business

The next mid-term initiative will be announced in May 2011.

38

0

20

40

60

80

100

'03 '04 '05 '06 '07 '08 '09 '10forecast

0

2

4

6

8

10

12

14Net income

Dividends per shareTarget: ≥¥10

¥8

¥6

¥10

¥12¥13

30.6% 19.9% 23.6% 24.5% 26.0% 295.0% 55.3% 32.9%

Aiming for higher ROE and payout ratio over the long term.

Payout ratio

(¥ billion) (¥ per share)

¥10¥10

Payout ratio of 1/3 as basic standard9. Concept for return to shareholders

FY

¥10

39

Appendix

40

Ishin-05

800

1,000

1,200

1,400

1,600

1,800

'98 '99 '00 '01 '02 '03* '04* '05* '06 '07 '08 '090

20

40

60

80

100

120

140Net sales (left scale)

Operating income (right scale)

Business performance and financial strength

Ishin2000 Growth Action – 2010

(¥ billion)

* Operating income from FY 2003 to 2005 prior to amortization of actuarial differences in retirement benefits.

(20)

(10)

0

10

20

30

40

Av erage f romFY00 to FY02

Av erage f romFY03 to FY05

Av erage f romFY06 to FY09

FCF after dividend(¥ billion)

Ishin-05 Growth Action – 2010

0

200

400

600

800

1,000

02 03 04 05 06 07 08 09

0.00

0.20

0.40

0.60

0.80

1.00Equity (left scale)Debt (left scale)D/E ratio (right scale)

(¥ billion)

FY

FY

41

Quarterly sales by segment

Q2forecast

Chemicals 195.0 227.2 156.7 110.4 132.9 160.3 159.0 169.8 178.4 207.6

Homes 63.7 106.6 112.1 127.5 58.5 99.2 96.0 136.0 64.5 109.5

Health Care 34.6 28.2 29.6 27.2 28.5 27.8 29.6 27.3 28.7 29.3

Fibers 30.7 33.4 28.1 24.2 22.4 26.3 25.9 26.6 26.5 26.5

Electronics 39.6 39.1 31.2 19.8 31.5 37.0 37.4 36.8 40.9 44.1

Construction Materials 14.7 16.6 16.7 12.9 11.6 13.0 12.4 10.1 11.0 13.0

 Others 7.7 6.2 5.4 8.0 3.9 5.7 3.8 4.3 3.5 5.5

Total 386.0 457.2 379.8 330.1 289.3 369.3 364.1 410.9 353.5 435.5

Q1

FY2009

Q4

FY2010FY2008*

Q3Q2Q1Q4Q3Q2 Q1

(¥

billion)

* FY 2008 figures adjusted to reflect the April 2009 transfer of operations as follows:- Transfer of Hipore™ Li-ion rechargeable battery separators, photopolymers, epoxy resins, and other related operations from Chemicals to Electronics.

- Transfer of Leona™ filament operations from Chemicals to Fibers.† Others category replaces the former Services, Engineering and Others segment.

†

42

Quarterly operating income by segment

Q2forecast

Chemicals 6.2 6.9 (2.3) (17.3) 2.2 9.3 10.3 4.2 15.3 16.7

Homes (3.7) 6.8 7.7 11.1 (3.0) 7.1 6.7 14.5 (0.9) 9.4

Health Care 9.0 1.2 2.8 (0.9) 3.1 0.3 2.9 (2.3) 3.3 0.2

Fibers 1.1 0.2 (0.5) (2.2) (1.5) (1.4) (0.0) 0.1 1.2 0.3

Electronics 6.8 5.8 1.2 (6.6) (0.6) 3.4 2.6 1.8 5.2 4.3

Construction Materials 0.3 0.5 1.0 (0.2) (0.0) 0.6 1.1 (0.5) 0.3 0.7

 Others 1.3 1.8 1.0 1.5 0.4 0.6 0.1 0.7 0.3 0.2

 Corporate Expenses and Eliminations

(1.6) (2.4) (1.1) (0.5) (1.0) (1.7) (1.7) (0.9) (2.0) (2.5)

Total 19.4 20.7 9.9 (15.1) (0.3) 18.3 22.0 17.7 22.8 29.2

Q1

FY2010

Q4

FY2008*

Q3Q2Q1Q4Q3Q2Q1

FY2009

(¥

billion)

* FY 2008 figures adjusted to reflect the April 2009 transfer of operations as follows: - Transfer of R&D for electronics materials such as Marketing Center for FPC/FPD Materials from corporate expenses, and Hipore™ Li-ion

rechargeable battery separators, photopolymers, epoxy resins, and other related operations from Chemicals to Electronics. - Transfer of Leona™ filament operations from Chemicals to Fibers.

† Others category replaces the former Services, Engineering and Others segment. Operating expenses of one consolidated subsidiary previously included in Services, Engineering and Others are now included in corporate expenses and eliminations (no impact on sales, immaterial impact on operating income).

†

43

2nd largest producer in the world, aiming for No. 1 position• Production capacity: 750 kt/y, 13% share

Development of world’s first propane process• Validation at commercial plant in Korea

from Jan. 07 to Feb. 08

Production of AN and MMA at JV with PTT of Thailand• 200 kt/y propane-process AN plant and

70 kt/y ACH-process MMA plant in late 2010

Aiming for global No.1 position in Acryronitrile

Acrylonitrile (AＮ)*

* Raw material for acrylic fiber (used in blankets and sweaters), ABS resin (used in household appliances), etc.

44

Top-tier world share: 22%Rapid demand growth in municipal water & sewage treatment, wastewater recovery• More stringent drinking water regulation in

US from 2011; requirement to remove 99.9997% of Cryptosporidium parvum

• Increasing water pollution/shortages in ChinaAccelerated development of wastewater recycling business• Operation start-up at first project in Suzhou, China, and start-up at

second project in late 20102 production sites, Japan and China• 30,000 module/y plant in Fuji, Japan • 30,000 module/y assembly plant in China

Microza™ hollow-fiber membrane for filtration

Growth of water treatment membrane business

45

Basic chemicals Caustic soda PE Membranes

Chlorine ABS, SAN

Ammonia PMMA pellet & sheet

Nitric acid Synthetic rubber & elastomer

Monomers Acrylonitrile Tenac™ POM

Styrene Xyron™ mPPE

MMA Leona™ nylon 66

Cyclohexanol

Adipic acid Explosives Defense explosives

Metal cladding

Saran Wrap™ cling film

Packaging products

Share of sales* Share of sales* 25%

* Based on results for FY 2009.

Volume productsSpecialty products

General-purposepolymers

Ceolus™ microcrystallinecellulose

Functionaladditives

Microza™ MF/UFmembranes

Ion-exchange membranes& systems

Duranate™ HDI-basedpolyisocyanate

Aluminum paste

SB latex

Performancechemicals

Performancepolymers

Home-use/Consumables

75%

Chemicals & derivative products Polymer products

Business portfolio of Chemicals

46

Volume products

Asahi Kasei Chemicals Main competitors

Main applications Asahi Kasei’s position/strengthsCapacity

(kt/y)Share

(%) CompanyCapacity

(kt/y)Share

(%)

Acrylonitrile 750 13 Ineos 1,324 23 Acrylic fiber, ABS resin; captive use for ABS, adiponitrile

2nd largest producer in the world

Styrene 710 2 ShellIneosDow

2,0702,0521,969

776

EPS, ABS, SB latex, unsaturated polyester, SBR; captive use for PS, ABS, SB latex, SBR

Largest production capacity in Japan

Methyl methacrylate

100 3 Mitsubishi Rayon

1,356 36 MS, MBS, coating materials; captive use for PMMA

Proprietary, cost- competitive C4 process

Cyclohexanol 170 Captive use for adipic acid Only producer in the world. Proprietary process

Adipic acid 170 6 InvistaRhodia

640455

2216

Polyurethane; captive use for nylon 66

Top-tier producer in Asia

Synthetic rubber (Solution-SBR)

85 14 Lanxess 115 18 Tires 2nd largest producer in the world; studying to construct new plant abroad to become No.1

* Share of production capacity, Asahi Kasei estimate.† Asahi Kasei estimate.

As of Sep. 1, 2010

* † *

47

Business field Product Position

Membranes Microza™ UF and MF membranes and systems

Top-tier world share: 22%

Aciplex™ ion-exchange membranes No. 1 world share: 45%

Electrolysis plants No. 1 world share: 30%

Performance chemicals Duranate™ HDI-based polyisocyanate No. 1 domestic share

Aluminum paste No. 2 domestic share

Polydurex™ silicone-modified acrylic latex, PVDC latex

PVDC latex, No. 2 world share: 20%

Functional additives Ceolus™ microcrystalline cellulose No. 3 world share

Specialty products

48

Technology advantage in Fibers

Roica™ high-function spandex• Acquisition of spandex plants in Germany and US

from Lanxess of Germany in Nov. 05; application of Roica™ technology at the plants

• World’s No. 3 share; global development of high- function and high-quality brand; production plants in Japan, Taiwan, China, Thailand, Germany, and US

Bemberg™ regenerated cellulose fiber• Only producer in the world• Shift from domestic lining market to global markets and

non-lining applicationsFull product lineup of nonwovens• Sales expansion with focus on Precisé™ multifunctional

nonwovenLeona™ nylon 66 filament with superior strength and thermal resistance• Sales expansion in automotive airbag application in addition to

tire cord application

Spandex, regenerated cellulose, nonwovens

Dormagen Plant for spandex, in Germany

49

“Long Life Home” strategy for Hebel Haus™

Exceptional resistance to earthquake and fire60-year inspection systemPioneer of urban three-story homes and two-generation homes • Launch of Hebel Haus™ Frex “G3” three-story homes

featuring next-generation energy conservation performance• Launch of Hebel Haus™ “i_co_i” as the latest

two-generation homes Strategic marketing • Development of urban markets from Kanto westward• Focus on rebuilding demand

More than 7 million houses in 3 largest areas are non-compliantwith current earthquake resistance standards

• Promotion with Hebel Haus™ “street-corner showrooms”Services for the ≈300,000 units sold to date• Steady increase in orders at remodeling business• Increased units under rent guarantee at real-estate business

Hebel Haus™ High-end urban homes and post- construction business

Hebel Haus™ Frex “G3”

50

Sales and order trends Homes

* Including commissions on property insurance.

(¥

billion, % change from same period of previous year shown at right)

Othersales*

Orderbacklog

FY06 H1 156.1 (+3.7%) 134.7 (‐3.9%) 6.0 (‐70.9%) 0.5 141.1 (‐12.4%) 28.0 (+15.7%) 169.1 (‐8.7%) 325.3

H2 147.3 (‐9.6%) 182.9 (+2.0%) 23.0 (+75.8%) 0.5 206.4 (+6.9%) 30.2 (+15.3%) 236.6 (+7.9%) 289.8

303.4 (‐3.2%) 317.6 (‐0.6%) 28.9 (‐13.8%) 1.0 347.5 (‐1.9%) 58.2 (+15.5%) 405.7 (+0.3%)

FY07 H1 153.6 (‐1.5%) 131.2 (‐2.6%) 5.0 (‐16.5%) 0.4 136.6 (‐3.2%) 30.3 (+8.2%) 166.9 (‐1.3%) 312.3

H2 152.5 (+3.5%) 165.9 (‐9.3%) 19.5 (‐15.1%) 0.5 186.0 (‐9.9%) 33.3 (+10.3%) 219.3 (‐7.3%) 298.8

306.1 (+0.9%) 297.1 (‐6.5%) 24.5 (‐15.4%) 1.0 322.5 (‐7.2%) 63.7 (+9.5%) 386.2 (‐4.8%)

FY08 H1 157.1 (+2.3%) 129.4 (‐1.4%) 6.0 (+19.7%) 0.7 136.0 (‐0.4%) 34.3 (+13.2%) 170.3 (+2.0%) 326.6

H2 133.9 (‐12.1%) 177.9 (+7.2%) 24.0 (+22.8%) 0.9 202.7 (+9.0%) 36.9 (+10.8%) 239.6 (+9.3%) 282.6

291.1 (‐4.9%) 307.3 (+3.4%) 29.9 (+22.2%) 1.5 338.7 (+5.0%) 71.2 (+11.8%) 409.9 (+6.1%)

FY09 Q1 76.4 (‐1.1%) 37.9 (‐14.6%) 2.6 (0.0%) 0.3 40.8 (‐13.5%) 17.7 (7.2%) 58.5 (‐8.2%) 321.1

Q2 78.2 (‐2.2%) 78.0 (‐8.3%) 2.6 (‐22.2%) 0.5 81.1 (‐8.8%) 18.1 (1.7%) 99.2 (‐6.9%) 321.3

H1 154.6 (‐1.6%) 115.8 (‐10.5%) 5.2 (‐12.6%) 0.8 121.9 (‐10.4%) 35.8 (4.4%) 157.7 (‐7.4%)

H2 152.3 (13.7%) 166.5 (‐6.4%) 26.9 (12.4%) 1.1 194.5 (‐4.1%) 37.5 (1.6%) 232.0 (‐3.2%) 307.1

306.9 (5.4%) 282.3 (‐8.1%) 32.1 (7.4%) 1.9 316.4 (‐6.6%) 73.4 (3.0%) 389.7 (‐4.9%)

FY10 Q1 89.3 (16.9%) 40.8 (7.7%) 4.6 (78.1%) 0.4 45.8 (12.3%) 18.7 (5.6%) 64.5 (10.3%) 355.7

85.7 (9.6%) 85.2 (9.3%) 5.4 (105.3%) 0.6 91.2 (12.5%) 18.3 (1.1%) 109.5 (10.4%) 356.1

175.0 (13.2%) 126.0 (8.8%) 10.0 (91.9%) 1.0 137.0 (12.4%) 37.0 (3.4%) 174.0 (10.3%)

FY10 324.0 (5.6%) 302.0 (7.0%) 34.0 (5.8%) 2.0 338.0 (6.8%) 78.0 (6.3%) 416.0 (6.7%) 329.1

Value of new ordersduring the term

ConsolidatedSales of order‐built homes

Sales of pre‐built homes

Non‐consolidated

Consolidatedsubsidiaries

annual

annual

annual

annual

Q2forecast

H1forecastforecastin May

51

World’s No. 2 share: 18%; Japan’s No. 1 share: 40%Plant expansions for polysulfone hollow-fibermembrane artificial kidneys• Integration of spinning and assembly lines in a new 5.5 million module/y plant for dry-pack polysulfone- membrane dialyzers in Nov. 08

• Hollow-fiber spinning capacity increase by 6 million module/y to 34 million module/y in Dec. 09

• 7.5 million module/y assembly plant in ChinaIntegration of dialyzer business with Kuraray Medical in Oct. 07• New 2.6 million module/y plant for EVOH hollow-fiber membrane in June 08

Business alliance with NxStage Medical, Inc. in May 09.Decision to acquire all shares of Med-tech Inc.; becoming a consolidated subsidiary of Asahi Kasei Kuraray Medical. In Oct.09.

Artificial kidney (hemodialyzer) business

Accelerated growth of artificial kidney business

Fresenius(Germany)

41%Gambro

(Sweden)17%

Other24%

(Asahi Kasei estimate)

Asahi Kasei Kuraray Medical 18%

World share

52

Advancing development in therapeutic apheresis - Expansion of difficult-to-treat indications to include

ulcerative colitis, rheumatoid arthritis, and Hepatitis C- Advancing overseas developmentExpansion of Sepacell™ leukocyte reduction filter business- 4 million modules/y capacity increase to

20 million modules/y in Apr. 09 Expansion of Planova™ virus removal filter business- Growing demand in production of plasma derivatives

and biopharmaceuticals - Expansion of hollow-fiber spinning plant by 40 thousand

m2/y to 70 thousand m2/y in Mar. 09- Expansion of assembly plant by 40 thousand m2/y to

80 thousand m2/y in Mar. 10- Acquisition of TechniKrom, Inc., a leading supplier of

bioprocess equipment

Global leadership in therapeutic apheresis devices

Therapeutic apheresis devices, leukocyte reduction filters, and virus removal filters

53

Pharmaceuticals (i)

Generic name Mechanism/substance class

Indication Formulation Co-development partner

FY09 sales (¥ billion)

Elcitonin™ Elcatonin Eel calcitonin derivative Osteoporosis pain Injection － 14.0

Flivas™ Naftopidil Selective α-1 blocker Benign prostatic hypertrophy Tablet － 13.7

Bredinin™ Mizoribine Immuno suppressant Kidney transplantation, lupus nephritis, nephrosis syndrome, rheumatoid arthritis

Tablet － 6.5

Toledomin™ Milnacipran hydrochloride

SNRI Depression Tablet － 5.0

Eril™ Fasudil Rho-kinase inhibitor Cerebral vasospasm after subarachnoid hemorrhage surgery

Injection － 1.4

Recomodulin™Market launch in May 2008

Recombinant thrombomodulin alpha

Blood coagulation Disseminated intravascular coagulation

Injection － 1.2

Famvir™Market launch in July 2008, distributed by Maruho

Famciclovir Antiviral Shingles (zoster) Tablet Novartis Pharma AG

－

Main products

54

Development stage Product Objective Class Indication

Phase IIIAT-877 (Injection)

Additional indication Rho-kinase inhibitor Acute cerebral infarction

PTH (Injection) New biologic Synthetic human

parathyroid hormone Osteoporosis

AK-120(Oral)

Additional indication Famciclovir antiviral Herpes simplex

Phase IIAT-877 (Oral)

Additional indication,new dosage form

Rho-kinase inhibitor Pulmonary hypertension

AK150 (Injection)

New chemical entity Pentosan polysulfate Osteoarthritis

Pharmaceuticals (ii)Product pipeline

55

Development in cell phone/communicationsand multimedia fields• World’s No. 1 share in audio devices in mixed-

signal LSIs• World’s No. 1 share in TCXO ICs• World’s No. 1 share in electronic compass; expansion

in smartphones and other portable terminals Reinforcement of design functions• Advantage in analog design – 2 years to

fully develop a digital-circuit design engineer, 10 years for an analog-circuit design engineer (design centers in Atsugi and Miyazaki)

Strengthening of marketing bases in Korea, China, Taiwan, and EuropeAcquisition of semiconductor business from Toko Inc. in Apr. 09

Product innovation for LSI market leadership

Analog/digital mixed-signal LSIs

Electronic compass

Plant in Plant in NobeokaNobeoka

56

Product/business development with combination of magnetic sensor and LSI Technology

Hall elements – magnetic sensors for motor control of DVD drives and PC fans• World’s No. 1 share in Hall elements: 70%

• Wafer processing plant for compound semiconductor in Fuji

Products fusing sensors & LSIs• Expansion in cell phone backlight switch and camera image

stabilization sensor applications

• Expansion in contact-free rotation angle sensor for automotive applications

Magnetic sensors and fusion products

Hall elements

Rotation angle sensor controller IC

57

World’s No. 1 share: 50%Full product lineup to meet specific market needsCapacity expansion from 150 million m2/yat end of FY09 to over 200 million m2/y in line with demand growth• Expansion by 30 million m2/y to 150 million m2/y in 2009 in Moriyama, Shiga• 55 million m2/y capacity in 2010 in Hyuga, Miyazaki, with new 20 million m2/y plant,

15 million m2/y expansion, and 20 million m2/y expansionAccelerated development of membranefor automotive Li-ion battery

Hipore™ Li-ion rechargeable battery separatorExpansion of Hipore™ business

Micrograph of large pore size Hipore™

Micrograph of small pore size Hipore™

58

Sunfort™ dry film photoresist (DF) for printed wiring boards• World top-3 share: 30% • The world’s largest DF plant in China; capacity expansion

of 100 million m2/y in Jun. 08 to 280 million m2/y• Total capacity 370 million m2/y, combined with

Fuji plant of 90 million m2/y capacityExpansion of ultra-thin glass fabricPimel™ semiconductor buffer coats• World’s No. 1 share • Expansion of alkaline type• New plant in Feb. 08Photomask pellicles for LSIs and LCDs• World top-3 share; nearly exclusive supplier

for large LCDs• New production line for pellicles for 10G LCD

panels in Nov. 08

Expansion of electronics materials business

Electronics materials

Pellicles

Dry film photoresist

59

Business field Product Position

Electronic devicesMixed-signal LSIs

World’s No. 1 share in TCXOs*, electronic compasses, and audio devices

Hall elements (magnetic sensors) World’s No. 1 share: 70%

Electronic materials Hipore™ Li-ion rechargeable battery separator World’s No. 1 share: 50%

Dry film photoresist World top-3 share: 30%

Glass fabric World’s No. 1 share in ultra-thin glass fabric

Pimel™ semiconductor buffer coats World’s No. 1 share in photosensitive products

Photomask pellicles World top-3 share; world’s No. 1 share for LCD panels

APR™ photosensitive resin, AFP™ photosensitive plates, printing plate making systems

World’s No. 2 share in photosensitive resin

Electronics products

* Temperature Compensated Crystal Oscillators.